$SKYQ | Is the "Green Oil" revolution finally hitting its parabolic stride, or are you about to become the next chapter of exit liquidity? While the retail crowd was paralyzed by the 1-for-8 reverse split in March, the "Smart Money" was quietly positioning for the perfect macro storm: Brent crude soaring past $110 and the critical Benicia refinery shutdown in California this month.
The objective data on our 4-hour chart is clinical. After a grueling Wave (b) correction that likely shook out every "weak hand" in the sector, $SKYQ has ignited a high-velocity Wave (c) impulse. At $8.54, we aren't just "bouncing"—we are entering a systematic expansion phase.
The Fundamental Pivot: Refining Scarcity vs. Energy Tech
The Macro Squeeze: With West Coast refining capacity shrinking and Brent crude at decade-highs, Sky Quarry’s Foreland Refinery in Nevada has transitioned from a niche asset to a strategic regional powerhouse. It is now the only operating refinery in Nevada, perfectly positioned to capture the summer demand surge.
The Tech Moat: Beyond just refining, the ECOSolv technology for asphalt recycling and the recently secured 10th patent for autonomous delivery infrastructure (via the Arrive AI integration) are building a multi-layered moat that the market is only just beginning to price in.
Technical Roadmap: Our Elliott Wave projections are surgical. We are currently hunting the $9.56 (1.529 extension) and the ultimate psychological barrier at $10.00 (1.618 extension).
The Veteran's Warning: If you are "bag-holding" from the pre-split highs, this vertical wick is your gift—but for those looking to "FOMO" at $8.50+, you are chasing a 25% intraday move. Professionals don't buy the top of the candle; they buy the structural "spring" before the expansion.
The "Smart Money" Execution
Are you still trapped in the old $SKYQ cost basis, or are you an aggressive day trader looking to ride the Wave (c) impulse toward $10.00? In a low-float, post-split environment, the "slippage" will liquidate you if you don't have a surgical entry and exit plan.
For my specific execution nodes and the real-time "Order Block" levels I am using to trade $SKYQ, reach out via the WhatsApp link in my bio.
#SKYQ #SkyQuarry #EnergyStocks #ElliottWave #TradingStrategy
$CHPT | The "Buy America" 100% domestic content mandate is a massive strategic tailwind for ChargePoint, yet the retail crowd is still paralyzed by the seasonal Q1 revenue guidance. While amateurs are distracted by the headline guidance of $90M–$100M, the 1-hour technical tape is delivering a clinical reversal signal.
The objective data on our chart is surgical. After a brutal consolidation phase, the REVERSAL PRO indicator has officially flipped to BULLISH. We have successfully established a systematic floor at the $5.24 – $5.27 structural nodes. Price is currently testing the $5.34 pivot, with the momentum oscillator in the top pane curling out of the exhaustion zone—a classic "Smart Money" accumulation signature.
The Fundamental Pivot: Operational Leverage vs. Market Fear
The Bull Case: The Q4 revenue beat ($109.3M) and a record 33% non-GAAP margin confirm the path to breakeven is real. The 68% reduction in cash burn is a game-changer for a company that bears previously tagged for bankruptcy.
The Policy Tailwind: With the NEVI program rebooted and Transportation Secretary Duffy’s 100% domestic content requirement for EV chargers, foreign competitors are sidelined. ChargePoint is effectively becoming the "Utility of the EV Era" in the U.S. market.
Technical Roadmap: We are tracking a recovery impulse toward the $5.55 – $5.65 resistance cluster. A high-volume break here opens the mathematical path toward the $6.64 macro reversal node.
Strategic Execution
If you are currently holding $CHPT from the $10+ rejections or looking to tactical play this structural floor, "hope" is not a risk management strategy. You need a data-driven framework to identify the exact institutional "buy-zones" and the immediate invalidation points before the next expansion phase begins.
Inquire via the WhatsApp link in my profile bio for the specific operation strategy and the daily invalidation levels for $CHPT.
#CHPT #EVCharging #PriceAction #TradingStrategy
$IBRX | ImmunityBio is currently the ultimate battleground between oncology breakthroughs and market gravity. While the "ANKTIVA" approval for bladder cancer was the fundamental catalyst that sent shares into a frenzy, the daily technical tape is delivering a clinical lesson in structural digestion. If you are holding from the $10.98 peak, you are currently witnessing the difference between a "miracle drug" and a "broken chart."
The objective data on the 1D chart is surgical. Our REVERSAL PRO indicator has transitioned into a NEUTRAL state. After the parabolic exhaustion at the $10.98 reversal node, price has entered a necessary cooling phase. We have successfully defended the $5.68 and $7.09 structural floors, and the current $8.12 print suggests a consolidation range is being established.
Fundamental Narrative vs. Technical Reality
The Bull Case: ANKTIVA (N-803) is a potential blockbuster. With FDA approval in hand for NMIBC and a strategic partnership with the Serum Institute of India, the commercialization runway is clear. Dr. Patrick Soon-Shiong's financial backing provides a "safety net" that most biotechs lack.
The Bear Case: The market is ruthlessly pricing in the "cost of success." Launching a specialized oncology drug requires massive capital, and the threat of dilution or high cash burn remains the primary weapon for shorts.
The Technical Signal: The momentum oscillator in the top pane has reset from extreme overbought levels. It is no longer in the "danger zone," but it hasn't yet printed the "deep red" exhaustion required for a high-conviction Wave 3 re-entry. We are currently in "no-man's land" between the $7.00 support and the $11.00 resistance.
The "Trap" Warning
If you are currently trapped in $IBRX from the double-digit highs or looking to deploy capital for the next multi-week recovery impulse, "hope" is not a risk management strategy. In this neutral state, price discovery often features "fake-out" wicks to hunt retail stops before the actual trend resumes.
Veteran traders wait for the structural pivot; rookies get washed out by the consolidation. To receive my specific execution roadmap and the institutional "order block" levels for $IBRX, reach out via the WhatsApp link in my profile bio.
#IBRX #ImmunityBio #ANKTIVA #BiotechTrading
$IBRX | The "bladder cancer breakthrough" narrative is a clinical marvel, but the 1-hour chart is delivering a brutal structural warning to retail traders who ignored the technical markdown. While ANKTIVA continues its commercial expansion, the tape is ruthlessly liquidating the "hope" of those who bought the rejections at the $12.00 and $9.12 nodes.
The objective data is undeniable: our 'REVERSAL PRO' indicator is locked in a firm BEARISH state. We have just witnessed a vertical Wave (5) capitulation that slammed the price down to the $7.30 structural floor. The momentum oscillator in the top pane is deep in the red "liquidity drain" zone, confirming that institutional players have been using retail "buy-the-dip" volume as exit liquidity for their distribution.
Fundamentally, ImmunityBio remains a high-stakes battleground. Despite the massive market potential for N-803, the relentless cash burn and the shadow of further dilution to fund the global launch are weighing heavily on the price. If you are blindly "averaging down" at these levels without a confirmed base, you are likely catching a falling knife in a technical vacuum.
However, from an Elliott Wave perspective, the completion of this 5-wave flush often leads to a high-probability Wave (4) corrective relief bounce. We have identified two primary Fibonacci recovery targets:
(4) 0.382 at $8.25
(4) 0.5 at $8.77
Entering now without knowing the exact volume triggers and the structural invalidation levels is a recipe for a secondary markdown. Veteran traders wait for the "spring" to be mathematically confirmed; rookies lose their capital to market-maker traps.
Detailed plan in my notes. [Link in Bio]
#IBRX #BiotechTrading #ImmunityBio #ElliottWave #MarketStructure #PriceAction #TradingStrategy
$CSIQ | The March 19th earnings "bloodbath" was a textbook liquidation event for retail traders who bought the solar hype too early. A massive -$1.66 EPS miss vs. the -$1.10 consensus is the kind of fundamental hit that forces weak hands to puke their positions at any price.
But let's look at the objective 45-minute structural data. While our REVERSAL PRO indicator remains firmly BEARISH, we are witnessing a clinical Wave (5) exhaustion at the $12.68 floor. This is precisely where the smart money hunts for oversold liquidity. The regression slope oscillator in the top pane is deep in the red but finally thinning out, suggesting the vertical markdown phase is reaching its limit.
Fundamentally, while the module shipment miss was brutal, the record $3.6B energy storage backlog provides a long-term cushion that the panic-sellers are currently ignoring. We are now mapping a high-probability Wave (a) corrective bounce from these lows. Our primary Fibonacci recovery targets sit at:
(a) 0.382 at $16.41
(a) 0.5 at $17.56
(a) 0.618 at $18.72
If you are trapped from the $20+ range or looking to catch this high-beta relief rally, do NOT trade on hope. You must know the exact volume triggers and the structural invalidation points near $12.50 before risking a single dollar. One failed bounce here could lead to a deeper capitulation toward the 52-week lows.
My detailed plan is in my notes. [Link in Bio]
#CSIQ #CanadianSolar #SolarStocks #ElliottWave #TechnicalAnalysis #MarketStructure #TradingStrategy
$AIRS (AirSculpt Technologies) is currently witnessing a massive technical and fundamental tug-of-war. The 4-hour chart has officially transitioned into a confirmed BULLISH trend following the $1.56 reversal floor, but the real story is the high-stakes activity occurring behind the scenes.
While the broader market initially reacted with uncertainty to the recent 10-K filing delay, the underlying fundamental data reveals a potential operational turnaround. Preliminary 2025 revenue reached $151.8 million, and February 2026 showed a return to positive comparable sales. Most significantly, a major 10% owner just executed a massive insider purchase between $2.43 and $2.70. This level of insider accumulation suggests that the smart money is positioning for a structural recovery that retail traders are still questioning.
Technically, the momentum oscillator is surging into positive territory, but the price is now approaching a critical structural resistance level at $3.14. For those who held through the brutal drawdown to $1.51, or those looking to capitalize on this current momentum, the next few sessions are crucial. We are approaching a zone where "exit liquidity" is often created for institutions.
Do not navigate these complex corporate developments and volatile chart structures based on headlines alone. We have mapped out the precise liquidity zones and the structural invalidation points for this recovery. Check the link in my bio to connect via WhatsApp for our specific execution strategy, price targets, and our professional roadmap for $AIRS.
$AIRS (AirSculpt Technologies) is currently witnessing a massive technical and fundamental tug-of-war. The 4-hour chart has officially transitioned into a confirmed BULLISH trend following the $1.56 reversal floor, but the real story is the high-stakes activity occurring behind the scenes.
While the broader market initially reacted with uncertainty to the recent 10-K filing delay, the underlying fundamental data reveals a potential operational turnaround. Preliminary 2025 revenue reached $151.8 million, and February 2026 showed a return to positive comparable sales. Most significantly, a major 10% owner just executed a massive insider purchase between $2.43 and $2.70. This level of insider accumulation suggests that the smart money is positioning for a structural recovery that retail traders are still questioning.
Technically, the momentum oscillator is surging into positive territory, but the price is now approaching a critical structural resistance level at $3.14. For those who held through the brutal drawdown to $1.51, or those looking to capitalize on this current momentum, the next few sessions are crucial. We are approaching a zone where "exit liquidity" is often created for institutions.
Do not navigate these complex corporate developments and volatile chart structures based on headlines alone. We have mapped out the precise liquidity zones and the structural invalidation points for this recovery. Check the link in my bio to connect via WhatsApp for our specific execution strategy, price targets, and our professional roadmap for $AIRS.
$SNDK finally cooling off after that vertical rip to $504.57. 📉 1H tape is resetting ahead of the Jan 29 earnings call. 🔭 Watching the $433.54 support pocket—if the NAND shortage story holds, this dip is a gift. 🎁 WhatsApp link in bio! 📲
$ONDS is gift-wrapping this entry. 🎁 Whales loaded at $16.45 & we’re holding $12 like a rock. This is the reset before the $16.72+ rip. 🚀 Drone defense is vertical. 🔭 WhatsApp in bio! 📲
$IBRX is playing for keeps. 🚀 Preliminary Q4 revenue just nuked expectations—up 700% YoY. The 15m tape is currently grinding through a healthy A-B-C reset. Watching the $7.75 relief pocket closely. 🔭 WhatsApp link in bio! 📲
$GLXY Wave (b) relief trap @ $34.73 confirmed. MMs selling the "1.6GW Helios" news into the BTC pullback. Flushing in Wave (c) toward the $20.02 abyss. New $100M fund launch is the next catalyst. 📉📉
Full maps? 👇 WhatsApp in bio!
$RKLB Success on the 2026 opener! 🚀 80th Electron mission is a wrap. MMs fading the Neutron tank rupture news from yesterday. Wave (a) testing $81.37 support. Watching for a (b) relief bounce to $90+ targets before the final reset. RSI cooling off. 📈📉
👇 WhatsApp in bio!
$FEDU plunging -27% to $7.99. 📉 Wave (c) is testing the critical $7.85 (1.490 Fib) support right now.
🐂 Bull: Watch for a base at $7.85-$7.04 floor for a relief bounce. 🐻 Bear: Resistance at $11.00.
Full trade plan? 👇 Check Bio to add WhatsApp. 📱
#FEDU#Stocks#Trading
$INVO resting at $1.92 after the massive pump. 📉 Algo showing a +51% upside signal building here.
🐂 Long: Hold $1.90 -> Target $2.27 gap fill. 🛑 Stop: STRICT below $1.80.
High risk, binary outcome play. Full setup? 👇 Check Bio to add WhatsApp. 📱
#INVO#PennyStocks#Trading
$VNET: Wave (5) peak confirmed @ $12.39. MMs trapping the bulls after the 10GW Green AI data center pump. Wave (a) tagged $9.52 support. Eyeing a (b) relief bounce to $10.91 before the final (c) wash out. RSI @ 47. 📉🚀 👇 WhatsApp in bio!
$THH: Absolute bloodbath. MMs nuked the $1.15 floor after the $55.0 peak. Total wipeout—$25M dilution rug-pull killed the buyback pump. RSI @ 30 shows zero mercy. Don't catch the falling knife. 📉 👇 WhatsApp in bio!
$VST: Wave 5 peak @ $184 confirmed. 📉 MMs shaking out the Meta hype after the recent 7% dump. RSI @ 42.9 near the $164 support. Watching for a (b) wave relief bounce. Meta PPAs & $7.2B 2026 guidance remain 🚀.
Full wave maps? 👇 WhatsApp in bio!
$THH Full capitulation. Wave (5) peak @ $55.04 confirmed—now retesting the $1.13 abyss. RSI @ 30.8 shows extreme blood. MMs nuked the buyback pump with that $25M dilution. Total wipeout. 📉
Full maps? 👇 WhatsApp in bio!
$DKNG Wave (5) peak confirmed @ $37.59. MMs trapping the Wells Fargo bulls after the $49 target hike. (a) leg tagging $32.84. Watching for (b) relief to the $34s-35s before (c) wash to $32.12. 👇 WhatsApp in bio!